JPMorgan prices $1.325M SPX Futures Barrier Notes
JPMorgan Chase Financial Company LLC priced $1,325,000 of Uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index due February 11, 2031.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
JPMorgan Chase Financial Company LLC priced $1,325,000 of Uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index due February 11, 2031. The notes priced on February 6, 2026 with expected settlement on or about February 11, 2026.
The notes have an Upside Leverage Factor of 2.0355, a Barrier Amount equal to 70.00% of the Initial Value (Initial Value: 562.19; Barrier level: 393.533) and pay at maturity: if Final Value > Initial Value, $1,000 + $1,000 × Index Return × 2.0355; if Final Value = Initial Value or ≥ Barrier, par ($1,000); if Final Value < Barrier, $1,000 + $1,000 × Index Return (losses possible up to full principal).
Price to public was $1,000 per note, selling commission $7.50, estimated value $973.60 per note. Payments are subject to issuer and guarantor credit risk of JPMorgan entities.
Insights
Notes provide doubled upside exposure above initial while exposing holders to barrier-triggered linear downside.
The structure offers an Upside Leverage Factor of 2.0355, meaning positive Index Returns are amplified by 2.0355 at maturity; the Barrier is 70.00% of the Initial Value (Initial Value: 562.19; Barrier: 393.533). Cash flows at maturity depend solely on the Index closing on the Observation Date February 6, 2031.
Key dependencies include the path to the Observation Date and the impact of futures roll/negative roll returns on the SPX Futures Excess Return Index. Secondary market liquidity is limited and the notes are unsecured obligations guaranteed by JPMorgan Chase & Co.
Tax treatment is uncertain; issuer counsel views the notes as open transactions but IRS could disagree.
Special tax counsel opines the notes may be treated as open transactions not as debt, yielding long-term capital gain/loss if held > one year. That position is not binding on the IRS and may be altered by future guidance, including rules discussed in the 2007 Treasury notice.
Section 871(m) treatment was assessed; issuer counsel expects 871(m) not to apply to Non-U.S. Holders for these notes, but the IRS could reach a different view. Consult tax adviser.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the size and settlement of the AMJB offering?
How do these notes pay at maturity for AMJB's SPX futures notes?
What are the key terms: Initial Value, Barrier, Upside Leverage for AMJB notes?
What was the issue price and estimated value per note for AMJB?
What are the main risks for holders of AMJB notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.